Clinical Trial Update: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Maridebart Cafraglutide to placebo in adults with obstructive sleep apnea not on PAP therapy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: RECRUITING